Owner New England Medical Center Hospitals, Inc. 1149336 Ontario, Inc. Trustees of Tufts College

Inventors Bachovchin, William; Plaut, Andrew G.; Drucker, Daniel

Agent Shelston IP

Pub. Number AU-A-2012202550

Parent 2011200657

Filing date 1 May 2012

Wipo publication date 24 May 2012

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 31/00 (2006.01)

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/15 (2006.01) - Oximes (CNO)

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/46 (2006.01) - 8-Azabicyclo [3.2.1] octane

A61K 31/48 (2006.01) - Ergoline derivatives, e.g. lysergic acid, ergotamine

A61K 31/69 (2006.01) - Boron compounds

A61K 31/702 (2006.01) - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/05 (2006.01) Medicinal preparations containing peptides - Dipeptides

A61K 38/28 (2006.01) Medicinal preparations containing peptides - Insulins

A61K 38/55 (2006.01) Medicinal preparations containing peptides - Protease inhibitors

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/08 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups